A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis

OBJECTIVE: We tested whether it is possible to differentiate relapsing-remitting (RR) from secondary progressive (SP) disease stages in patients with multiple sclerosis (MS) using a combination of nuclear magnetic resonance (NMR) metabolomics and partial least squares discriminant analysis (PLS-DA)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurology
Autors principals: Dickens, Alex M., Larkin, James R., Griffin, Julian L., Cavey, Ana, Matthews, Lucy, Turner, Martin R., Wilcock, Gordon K., Davis, Benjamin G., Claridge, Timothy D.W., Palace, Jacqueline, Anthony, Daniel C., Sibson, Nicola R.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4222850/
https://ncbi.nlm.nih.gov/pubmed/25253748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000905
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars